Prostaglandin E2 Reverses the Effects of DNA Methyltransferase Inhibitor and TGFB1 on the Conversion of Naive T Cells to iTregs
Open Access
- 19 September 2019
- journal article
- research article
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 47 (3) , 244-253
Abstract
Naturally occurring regulatory T cells (nTregs) are produced under thymic (tTregs) or peripherally induced (pTregs) conditions in vivo. On the other hand, Tregs generated from naive T cells in vitro under some circumstances, such as treatment with transforming growth factor-β (TGFB), are called induced Tregs (iTregs). Tregs are especially characterized by FOXP3 expression, which is mainly controlled by DNA methylation. nTregs play important roles in the suppression of immune response and self-tolerance. The prostaglandin E2 (PGE2) pathway was reported to contribute to regulatory functions of tumor-infiltrating nTregs. In this study, we examined whether PGE2 contributes to the formation of iTregs treated with TGFB1 and 5-aza-2′-deoxycytidine (5-aza-dC), which is a DNA methyltransferase inhibitor. We found that the protein and gene expression levels of FOXP3 and IL-10 were increased in 5-aza-dC and TGFB1-treated T cells in vitro. However, the addition of PGE2 to these cells reversed these increments significantly. In CFSE-based cell suppression assays, we demonstrated that PGE2 decreased the suppressive functions of 5-aza-dC and TGFB1-treated T cells.Keywords
This publication has 64 references indexed in Scilit:
- CD4+T Cells: Differentiation and FunctionsJournal of Immunology Research, 2012
- Prostaglandin E2 promotes intestinal tumor growth via DNA methylationNature Medicine, 2012
- Increased methylation variation in epigenetic domains across cancer typesNature Genetics, 2011
- Epigenetic mechanisms of regulation of Foxp3 expressionBlood, 2009
- Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signalingJournal of Experimental Medicine, 2009
- Global Hypomethylation of Genomic DNA in Cancer-Associated MyofibroblastsCancer Research, 2008
- Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancerBMC Cancer, 2008
- CREB/ATF-dependent T cell receptor–induced FoxP3 gene expression: a role for DNA methylationJournal of Experimental Medicine, 2007
- Role of IFN-g in induction of Foxp3 and conversion of CD4+CD25- T cells to CD4+ TregsJournal of Clinical Investigation, 2006
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004